Ex vivo expansion of regulatory T cells for clinical applications against graft-versus-host disease

来源 :中华医学杂志(英文版) | 被引量 : 0次 | 上传用户:X395381435
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
Objective To review the characteristics of regulatory T cells (Tregs) and ex vivo expansion of Tregs for treatment of graftversus-host disease (GVHD).Data sources The data used in this review were retrieved from PubMed (1970-2013).The terms ex vivo expansion,regulatory T cell,and graft-versus-host disease were used for literature search.Study selection The publications about the characteristics of Tregs,ex vivo expansion of Tregs and clinical applications of Tregs against GVHD were identified,retrieved and reviewed.Results Tregs can be classified as natural Tregs (nTregs) and induced Tregs (iTregs).Both subsets share most Treg features.Given their immunosuppressive property,Tregs have been tested for their capability of preventing GVHD.The bottleneck of Treg therapy is the limited numbers of naturally existing Tregs.To solve this problem,ex vivo expansion of nTregs or iTregs has been executed.The initial data indicate Treg therapy is effective in reducing GVHD without compromising graft-versus-leukemia (GVL).Conclusion Ex vivo expansion of Tregs is a reliable way to prepare sufficient number of Tregs for management of GVHD.
其他文献
目的 研究破淤通络汤对脑梗死的疗效.方法 对64例确诊脑梗死患者应用破淤通络汤治疗后临床疗效观察对比,评价药物疗效.结果 试验组患者治疗前后症状明显改善,对照组改善不明
目的比较应用加长骶髂螺钉和长骶髂螺钉以不同方式固定中央型骶骨纵行骨折的生物力学特征,为临床应用提供参考依据。方法使用三维有限元方法,建立中央型骶骨纵行骨折(Tile C型骨盆损伤)模型,分别模拟7种不同长度骶髂螺钉固定方式,包括:(1)右侧1枚长骶髂螺钉对骶1进行固定(C1);(2)右侧1枚长骶髂螺钉对骶2进行固定(C2);(3)骶1和骶2各1枚长骶髂螺钉自右侧进行固定(C12);(4)右侧1枚骶
介绍了AOD炉运用氮气在不锈钢中溶解与脱除理论所开发的氮合金化工艺。在40tAOD炉上冶炼0Cr19Ni9N、0Cr19Ni9NbN、1Cr17Mn6Ni5N、00Cr18Ni5Mo3Si2(N)、00Cr22Ni5Mo3N等含氮不
Background Combination paclitaxel and carboplatin is currently a first-line regimen for ovarian cancer.However,many patients develop tumor recurrence or drug re
从整体设计观念出发,分析城市道路空间景观的构成要素和设计要点,旨在使道路设计与城市规划、建筑设计等系统紧密站结合,形成城市道路空间景观的有机设计方法.
Background Sensitive and specific biomarkers for identifying early stage of non-small cell lung cancer (NSCLC) are urgently needed to improve the therapeutic ou